These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38885377)

  • 1. Structural basis for activation of somatostatin receptor 5 by cyclic neuropeptide agonists.
    Li J; You C; Li Y; Li C; Fan W; Chen Z; Hu W; Wu K; Xu HE; Zhao LH
    Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2321710121. PubMed ID: 38885377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into somatostatin receptor 5 bound with cyclic peptides.
    Li YG; Meng XY; Yang X; Ling SL; Shi P; Tian CL; Yang F
    Acta Pharmacol Sin; 2024 Jun; ():. PubMed ID: 38926478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20.
    Tallent M; Liapakis G; O'Carroll AM; Lolait SJ; Dichter M; Reisine T
    Neuroscience; 1996 Apr; 71(4):1073-81. PubMed ID: 8684611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug design at peptide receptors: somatostatin receptor ligands.
    Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
    J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors.
    Streuli J; Harris AG; Cottiny C; Allagnat F; Daly AF; Grouzmann E; Abid K
    Neuropeptides; 2018 Apr; 68():84-89. PubMed ID: 29523357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
    Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
    Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
    Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
    Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
    Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
    J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice.
    Kaczmarek P; Singh V; Cashen DE; Yang L; Berk S; Pasternak A; Xiong Y; Shen DM; Hutchins SM; Chapman K; Wiedenmann B; Schaeffer JM; Strowski MZ
    Neurogastroenterol Motil; 2010 Feb; 22(2):204-9, e66. PubMed ID: 19754922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.
    Kong H; Raynor K; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
    Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
    J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the selective G protein signaling of somatostatin receptors.
    Chen S; Teng X; Zheng S
    Nat Chem Biol; 2023 Feb; 19(2):133-140. PubMed ID: 36138141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation affects agonist binding and signal transduction of the rat somatostatin receptor subtype 3.
    Nehring RB; Richter D; Meyerhof W
    J Physiol Paris; 2000; 94(3-4):185-92. PubMed ID: 11087995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin analogs for diagnosis and treatment of cancer.
    Weckbecker G; Raulf F; Stolz B; Bruns C
    Pharmacol Ther; 1993 Nov; 60(2):245-64. PubMed ID: 7912834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
    Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-EM structure of the human somatostatin receptor 2 complex with its agonist somatostatin delineates the ligand-binding specificity.
    Heo Y; Yoon E; Jeon YE; Yun JH; Ishimoto N; Woo H; Park SY; Song JJ; Lee W
    Elife; 2022 Apr; 11():. PubMed ID: 35446253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion.
    Ren SG; Taylor J; Dong J; Yu R; Culler MD; Melmed S
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4239-45. PubMed ID: 12970293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.
    Stueven AK; Kayser A; Wetz C; Amthauer H; Wree A; Tacke F; Wiedenmann B; Roderburg C; Jann H
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular simulations of SSTR2 dynamics and interaction with ligands.
    Gervasoni S; Guccione C; Fanti V; Bosin A; Cappellini G; Golosio B; Ruggerone P; Malloci G
    Sci Rep; 2023 Mar; 13(1):4768. PubMed ID: 36959237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.